Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Japan gov't panel approves 2 iPS-derived drugs

OSAKA, Japan, Feb. 19 Kyodo - University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university. (Kyodo)

E

Japan gov't panel approves 2 iPS-derived drugs

University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.

E

Japan gov't panel approves 2 iPS-derived drugs

University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.

E

Japan gov't panel approves 2 iPS-derived drugs

University of Osaka professor Yoshiki Sawa holds a press conference in Osaka on Feb. 19, 2026, after Japan's health ministry panel approved the commercialization of two regenerative medicine products prepared from iPS cells, the first of their kind in the world. One of the two drugs, ReHeart, heart muscle sheets derived from human iPS cells, was developed by a startup originating from Sawa's team at the university.

E

Cell sheet successfully transplanted to girl's heart

OSAKA, Japan - Yoshiki Sawa, a professor in the Department of Cardiovascular Surgery at Osaka University Hospital, talks in Suita, Osaka Prefecture, western Japan, on July 23, 2014, about his team's successful transplant of a sheet of cells to the heart of an 11-year-old girl, stricken with a grave heart disease, and subsequent improvement in her heart's functions. The cells were cultivated after being taken from the girl's own calf muscle tissue. It is believed to be the world's first such surgery performed on a child.

E

iPS-derived cells become part of rat's heart tissue, doctor says

Osaka University professor Yoshiki Sawa, a cardiovascular surgeon, reports at a press conference in Osaka, western Japan, on Jan. 25, 2015, that a cardiac muscle sheet of induced pluripotent stem (iPS) cells has assimilated with the heart tissue of a rat. (Kyodo) ==Kyodo

E

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

E

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

E

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa (L) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

E

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa (R) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

E

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

E

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo